Literature DB >> 34219762

Laparoscopic esophagopexy, fundopexy, and hiatal herniorrhaphy for refractory regurgitation in a racing Alaskan husky sled dog.

Nathan L Cherzan1, Boel A Fransson1.   

Abstract

A 2-year-old intact female Alaskan husky sled dog was presented with a history of chronic exercise-induced regurgitation refractory to medical management. Previous diagnostics were unremarkable except for an endoscopic examination and histopathologic evaluation of the upper gastrointestinal tract that revealed the presence of Helicobacter spp. and mild non-specific inflammation of the proximal duodenum. A laparoscopic hiatal herniorrhaphy, esophagopexy, fundopexy, and ovariectomy were performed without complications in anesthesia or surgery and clinical improvement was observed with continued follow-up for 8 months after surgery. Key clinical message: Surgical treatment for hiatal hernia may be considered in racing Alaskan sled dogs with regurgitation refractory to gastric protectant therapy. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Year:  2021        PMID: 34219762      PMCID: PMC8118179     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  12 in total

1.  Sustained strenuous exercise increases intestinal permeability in racing Alaskan sled dogs.

Authors:  Michael S Davis; Michael D Willard; Katherine K Williamson; Jörg M Steiner; David A Williams
Journal:  J Vet Intern Med       Date:  2005 Jan-Feb       Impact factor: 3.333

2.  Changes of left ventricular diastolic function in exercising dogs without and with ischemia.

Authors:  S Miyazaki; B D Guth; T Miura; C Indolfi; R Schulz; J Ross
Journal:  Circulation       Date:  1990-03       Impact factor: 29.690

3.  Temporal relationship between gastrointestinal protein loss, gastric ulceration or erosion, and strenuous exercise in racing Alaskan sled dogs.

Authors:  Michael Davis; Michael Willard; Katherine Williamson; Chris Royer; Mark Payton; Jörg M Steiner; Kenneth Hinchcliff; Erica McKenzie; Stuart Nelson
Journal:  J Vet Intern Med       Date:  2006 Jul-Aug       Impact factor: 3.333

4.  Total laparoscopic gastropexy using 1 simple continuous barbed suture line in 63 dogs.

Authors:  Joel D Takacs; Ameet Singh; J Brad Case; Philipp D Mayhew; Michelle A Giuffrida; Ana V Caceres; W Alexander Fox-Alvarez; Jeffrey J Runge
Journal:  Vet Surg       Date:  2016-12-19       Impact factor: 1.495

5.  Assessment of necropsy findings in sled dogs that died during Iditarod Trail sled dog races: 23 cases (1994-2006).

Authors:  Michelle M Dennis; Stuart N Nelson; Glenn H Cantor; Derek A Mosier; John E Blake; Randall J Basaraba
Journal:  J Am Vet Med Assoc       Date:  2008-02-15       Impact factor: 1.936

6.  Prevalence of gastric lesions in racing Alaskan sled dogs.

Authors:  M S Davis; M D Willard; S L Nelson; R E Mandsager; B S McKiernan; J K Mansell; T W Lehenbauer
Journal:  J Vet Intern Med       Date:  2003 May-Jun       Impact factor: 3.333

Review 7.  Hiatal hernia controversies--a review of pathophysiology and treatment options.

Authors:  R K Sivacolundhu; R A Read; A M Marchevsky
Journal:  Aust Vet J       Date:  2002 Jan-Feb       Impact factor: 1.281

8.  Documenting the prevalence of hiatal hernia and oesophageal abnormalities in brachycephalic dogs using fluoroscopy.

Authors:  E J Reeve; D Sutton; E J Friend; C M R Warren-Smith
Journal:  J Small Anim Pract       Date:  2017-09-30       Impact factor: 1.522

9.  Efficacy of omeprazole versus high-dose famotidine for prevention of exercise-induced gastritis in racing Alaskan sled dogs.

Authors:  K K Williamson; M D Willard; M E Payton; M S Davis
Journal:  J Vet Intern Med       Date:  2010 Mar-Apr       Impact factor: 3.333

10.  Efficacy of omeprazole for the prevention of exercise-induced gastritis in racing Alaskan sled dogs.

Authors:  M S Davis; M D Willard; S L Nelson; S M McCullough; R E Mandsager; J Roberts; M E Payton
Journal:  J Vet Intern Med       Date:  2003 Mar-Apr       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.